The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incid...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4625015?pdf=render |
id |
doaj-1acf66b574964583b3d832a7406a83ba |
---|---|
record_format |
Article |
spelling |
doaj-1acf66b574964583b3d832a7406a83ba2020-11-24T20:50:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014142510.1371/journal.pone.0141425The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.Cheuk-Chun SzetoBonnie C H KwanKai-Ming ChowPhyllis M S ChengVickie W K KwongAgnes S M ChoyMan-Ching LawChi-Bon LeungPhilip K T LiPrevious studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV.After 52 weeks, Intervention Group had higher overhydration (3.1 ± 2.6 vs 1.9 ± 2.2 L, p = 0.045) and extracellular water volume (17.7 ± 3.9 vs 15.8 ± 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 ± .0.61 vs 0.90 ± 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 ± 0.77 vs 4.91 ± 0.95 mg/dL, p < 0.0001).Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study.ClinicalTrials.gov NCT00966615.http://europepmc.org/articles/PMC4625015?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Cheuk-Chun Szeto Bonnie C H Kwan Kai-Ming Chow Phyllis M S Cheng Vickie W K Kwong Agnes S M Choy Man-Ching Law Chi-Bon Leung Philip K T Li |
spellingShingle |
Cheuk-Chun Szeto Bonnie C H Kwan Kai-Ming Chow Phyllis M S Cheng Vickie W K Kwong Agnes S M Choy Man-Ching Law Chi-Bon Leung Philip K T Li The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. PLoS ONE |
author_facet |
Cheuk-Chun Szeto Bonnie C H Kwan Kai-Ming Chow Phyllis M S Cheng Vickie W K Kwong Agnes S M Choy Man-Ching Law Chi-Bon Leung Philip K T Li |
author_sort |
Cheuk-Chun Szeto |
title |
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. |
title_short |
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. |
title_full |
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. |
title_fullStr |
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. |
title_full_unstemmed |
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial. |
title_sort |
effect of neutral peritoneal dialysis solution with low glucose-degradation-product on the fluid status and body composition--a randomized control trial. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV.After 52 weeks, Intervention Group had higher overhydration (3.1 ± 2.6 vs 1.9 ± 2.2 L, p = 0.045) and extracellular water volume (17.7 ± 3.9 vs 15.8 ± 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 ± .0.61 vs 0.90 ± 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 ± 0.77 vs 4.91 ± 0.95 mg/dL, p < 0.0001).Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study.ClinicalTrials.gov NCT00966615. |
url |
http://europepmc.org/articles/PMC4625015?pdf=render |
work_keys_str_mv |
AT cheukchunszeto theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT bonniechkwan theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT kaimingchow theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT phyllismscheng theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT vickiewkkwong theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT agnessmchoy theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT manchinglaw theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT chibonleung theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT philipktli theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT cheukchunszeto effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT bonniechkwan effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT kaimingchow effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT phyllismscheng effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT vickiewkkwong effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT agnessmchoy effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT manchinglaw effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT chibonleung effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial AT philipktli effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial |
_version_ |
1716804971640389632 |